Pharmasol Expands Pharmacovigilance Presence

pharmasol, a specialist software and full-service solutions provider that works to optimize pharmacovigilance processes, has officially merged with PharmaLex Group, a specialized services source for the pharma, biotech and medtech industries.

The information technology company offers pharmacovigilance and end-to-end business support knowledge to the expanded group, extending the solution footprint of PharmaLex’s Technology-Enabled Smart Services (TESS) division. The company allows organizations to implement, automate and optimize regulatory duties, including SUSAR (Suspected Unexpected Serious Adverse Reactions) distribution via its industry-leading psiXchange platform.

“This strategic partnership with PharmaLex is a key milestone in our mission to create a dominant market position and enhance our total solution portfolio offering to our clients,” notes pharmasol CEO Torsten Adam. “This landmark alliance empowers both organizations to offer greater depth and breadth of service in the fast-growing and highly competitive area of pharmacovigilance.”